These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28097378)

  • 1. [Molecular pathogenesis of Duchenne muscular dystrophy-related fibrosis].
    Ohlendieck K; Swandulla D
    Pathologe; 2017 Feb; 38(1):21-29. PubMed ID: 28097378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
    Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
    J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis.
    Holland A; Dowling P; Meleady P; Henry M; Zweyer M; Mundegar RR; Swandulla D; Ohlendieck K
    Proteomics; 2015 Jul; 15(13):2318-31. PubMed ID: 25737063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.
    Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K
    J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Matrix Proteomics: The
    Dowling P; Gargan S; Zweyer M; Swandulla D; Ohlendieck K
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from
    Murphy S; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
    Proteomes; 2015 Sep; 3(3):298-327. PubMed ID: 28248273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.
    Fallon JR; McNally EM
    Matrix Biol; 2018 Aug; 68-69():616-627. PubMed ID: 29481844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta1 treatment.
    Zanotti S; Gibertini S; Mora M
    Cell Tissue Res; 2010 Feb; 339(2):397-410. PubMed ID: 19902258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy.
    Desguerre I; Arnold L; Vignaud A; Cuvellier S; Yacoub-Youssef H; Gherardi RK; Chelly J; Chretien F; Mounier R; Ferry A; Chazaud B
    Muscle Nerve; 2012 Jun; 45(6):803-14. PubMed ID: 22581532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle.
    Haslett JN; Sanoudou D; Kho AT; Bennett RR; Greenberg SA; Kohane IS; Beggs AH; Kunkel LM
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15000-5. PubMed ID: 12415109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy.
    Carberry S; Zweyer M; Swandulla D; Ohlendieck K
    Int J Mol Med; 2012 Aug; 30(2):229-34. PubMed ID: 22614334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.
    Desguerre I; Mayer M; Leturcq F; Barbet JP; Gherardi RK; Christov C
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):762-73. PubMed ID: 19535995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.
    Holland A; Murphy S; Dowling P; Ohlendieck K
    Proteomics; 2016 Jan; 16(2):345-66. PubMed ID: 26256116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease.
    Fadic R; Mezzano V; Alvarez K; Cabrera D; Holmgren J; Brandan E
    J Cell Mol Med; 2006; 10(3):758-69. PubMed ID: 16989735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the process of fibrosis in Duchenne muscular dystrophy.
    Kharraz Y; Guerra J; Pessina P; Serrano AL; Muñoz-Cánoves P
    Biomed Res Int; 2014; 2014():965631. PubMed ID: 24877152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology.
    Berger J; Berger S; Hall TE; Lieschke GJ; Currie PD
    Neuromuscul Disord; 2010 Dec; 20(12):826-32. PubMed ID: 20850317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with rGDF11 does not improve the dystrophic muscle pathology of mdx mice.
    Rinaldi F; Zhang Y; Mondragon-Gonzalez R; Harvey J; Perlingeiro RCR
    Skelet Muscle; 2016; 6():21. PubMed ID: 27303621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.
    Zweyer M; Sabir H; Dowling P; Gargan S; Murphy S; Swandulla D; Ohlendieck K
    Histol Histopathol; 2022 Feb; 37(2):101-116. PubMed ID: 34873679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.